RayzeBio · 6 hours ago
Auditor, Vendor Quality
Maximize your interview chances
BiotechnologyHealth Care
Insider Connection @RayzeBio
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Author and maintain external audit schedule
Schedule and coordinate external vendor audits
Review, communicate and track audit findings
Create, review, approve, and track corrective actions related to external audits.
Support the review, discussion and approval of Quality Agreements for external vendors
Participate in vendor reviews, provide input for the topics that relate to vendor performance and audits outcome.
Support site activities that relate to the vendor change notification program and vendor complaint management program.
Help establish and maintain the Vendor Management program
50% of travel or as required
Direct communication to Vendor, schedule and conduct on site, virtual or paper audit/assessment
Report writing and Vendor performance metrics
Ensure suppliers are qualified and conduct audits at defined frequencies as part of the supplier monitoring process.
Supporting an early phase to commercial facility
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
4-year science degree
5 years of GMP Pharmaceutical manufacturing or equivalent, late phase and commercial preferred
FDA CFR and EU Annex regulations
Analytical problem solving
Pharmaceutical manufacturing with parenteral experience
Writing procedures, reports, metrics and dashboard
Preferred
advanced degree
ASQ Auditing certificate or equivalent
Experience with Electronic Quality Management Systems (EQMS) such as SAP, TrackWise, MasterControl, and Veeva
Knowledge in microbiology and radiopharmaceuticals
Benefits
Incentive cash and stock opportunities
Company
RayzeBio
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Funding
Current Stage
Public CompanyTotal Funding
$418MKey Investors
Venrock Healthcare Capital Partners
2023-12-26Acquired· by Bristol-Myers Squibb
2023-09-15IPO· nasdaq:RYZB
2022-09-13Series D· $160M
Leadership Team
Recent News
InvestorPlace
2024-05-05
Company data provided by crunchbase